Document Detail


Azelnidipine exerts renoprotective effects by improvement of renal microcirculation in angiotensin II infusion rats.
MedLine Citation:
PMID:  19666664     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Hypoxia-induced tubulointerstitial injury caused by loss of peritubular capillary (PTC) blood flow may be associated with progressive renal disease. Therefore, the maintenance of blood flow in PTCs may protect against loss of renal function. A long-acting calcium channel blocker, azelnidipine, has been shown to be useful in the treatment of progressive renal disease. However, its mechanism of action remains unclear. The aim of the present study was to elucidate whether azelnidipine maintains PTC blood flow and to compare it to nifedipine in its ability to improve tubulointerstitial injury caused by angiotensin II (AII) infusion in rats. METHODS: PTC blood flow was initially monitored using a pencil-lens interval microscope before and after intravenous AII (30 ng/kg/min) infusion with or without azelnidipine (10 microg/kg/min). Next, Wistar rats were treated with chronic infusion of AII (500 ng/kg/min) via an osmotic minipump with or without azelnidipine (3 mg/kg/day, orally) or nifedipine (60 mg/kg/day, orally) for 14 days, and tubulointerstitial damage (PTC loss, interstitial fibrosis, tubular atrophy) was examined. RESULTS: PTC blood flow was reduced after AII infusion but improved after a bolus injection of azelnidipine. Tubulointerstitial damage observed in chronically AII-treated kidneys was associated with hypoxic conditions, as indicated by the measurement of hypoxia biomarkers (intracellular hypoxyprobe-1 adducts). These tubulointerstitial injuries in AII-infused rats were more effectively reduced by azelnidipine than by nifedipine. The area showing hypoxic conditions in the kidney was also more reduced with azelnidipine than nifedipine treatment. CONCLUSIONS: Azelnidipine may increase PTC blood flow and improve renal hypoxia and tubulointerstitial injury induced by AII infusion.
Authors:
Sohachi Fujimoto; Minoru Satoh; Hajime Nagasu; Hideyuki Horike; Tamaki Sasaki; Naoki Kashihara
Related Documents :
3332844 - Aortic stump closure: a new technique.
5033844 - The effect of octapressin on renal and intrarenal blood flow in cirrhosis of the liver.
230544 - Evidence for separate pgd2 and pgf2 alpha receptors in the canine mesenteric vascular bed.
961744 - Renal clearances of estriol conjugates in normal human pregnancy at term.
9250254 - Laboratory and clinical evaluation of a portable computerized peak flow meter.
8956954 - Giving both enoxaparin and dextran increases the need for transfusion in revision hip a...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-08-07
Journal Detail:
Title:  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association     Volume:  24     ISSN:  1460-2385     ISO Abbreviation:  Nephrol. Dial. Transplant.     Publication Date:  2009 Dec 
Date Detail:
Created Date:  2009-11-25     Completed Date:  2010-02-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8706402     Medline TA:  Nephrol Dial Transplant     Country:  England    
Other Details:
Languages:  eng     Pagination:  3651-8     Citation Subset:  IM    
Affiliation:
Division of Nephrology, Department of Internal Medicine, Kawasaki Medical School, Kurashiki, Okayama, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin II / administration & dosage
Animals
Azetidinecarboxylic Acid / analogs & derivatives*,  therapeutic use
Calcium Channel Blockers / therapeutic use*
Dihydropyridines / therapeutic use*
Infusions, Intravenous
Male
Microcirculation / drug effects*
Nephritis, Interstitial / physiopathology*,  prevention & control*
Nifedipine / therapeutic use*
Rats
Rats, Wistar
Renal Circulation / drug effects*
Chemical
Reg. No./Substance:
0/Calcium Channel Blockers; 0/Dihydropyridines; 11128-99-7/Angiotensin II; 123524-52-7/azelnidipine; 21829-25-4/Nifedipine; 2517-04-6/Azetidinecarboxylic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Human uraemic plasma stimulates release of leptin and uptake of tumour necrosis factor-{alpha} in vi...
Next Document:  Celecoxib treatment reduces peritoneal fibrosis and angiogenesis and prevents ultrafiltration failur...